Takeda Oncology Here2Assist RapidStart Program: Fruzaqla
Not Funded
About
The Takeda Oncology Here2Assist RapidStart Program: Fruzaqla offers a compelling solution for patients new to Fruzaqla therapy by providing a 1-month supply of the medication at no charge. This program is designed to mitigate the impact of insurance delays, ensuring patients can begin their treatment promptly. By enrolling in the Takeda Oncology Here2Assist Program, patients with an on-label prescription for Fruzaqla may benefit from this valuable support during coverage determination delays.
Insurance requirements: Commercially insured, Underinsured
Enrollment Forms
Enrollment Form
Benefits
•1 maximum fills per year
Program Requirements
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: No
•Activation Required: No
Program Details
•The RapidStart Program provides a 1month supply of treatment of the prescribed Takeda Oncology medication at no charge for eligible patients new to therapy experiencing a delay in insurance coverage determination
•Free product for the RapidStart Program will only be available through the RapidStart Program noncommercial specialty pharmacy
•A delay in coverage determination of at least 5 days is required for patients to be eligible for the RapidStart Program
•For assistance or additional information, call 8448176468, Option 2, MondayFriday, 8AM8PM ET
Enrollment Forms
Enrollment Form